Pancreatic Ductal Adenocarcinoma Not Yet Recruiting Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0034446 (Pancreatic Ductal Adenocarcinoma)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04146298Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic CancerTreatment